Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5967)
All Articles published online
|
Mar 21, 2009 (publication date) through Nov 3, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Gomaa AI, Khan SA, Leen EL, Waked I, Taylor-Robinson SD. Diagnosis of hepatocellular carcinoma. World J Gastroenterol 2009; 15(11): 1301-1314 [PMID: 19294759 DOI: 10.3748/wjg.15.1301] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v15/i11/1301.htm |
| Number | Citing Articles |
| 1 |
Manar M. Ismail, Heba K. Morsi, Nahla A. B. Abdulateef, Maissa K. Noaman, Ghada A. Abou El-Ella. Evaluation of prothrombin induced by vitamin K absence, macrophage migration inhibitory factor and Golgi protein-73 versus alpha fetoprotein for hepatocellular carcinoma diagnosis and surveillance. Scandinavian Journal of Clinical and Laboratory Investigation 2017; 77(3): 175 doi: 10.1080/00365513.2017.1286684
|
| 2 |
Giuseppe Derosa, Pamela Maffioli. Biomarkers in Liver Disease. Biomarkers in Disease: Methods, Discoveries and Applications 2017; : 3 doi: 10.1007/978-94-007-7675-3_13
|
| 3 |
John FP Bridges, Gisselle Gallego, Barri M Blauvelt. Controlling liver cancer internationally: A qualitative study of clinicians' perceptions of current public policy needs. Health Research Policy and Systems 2011; 9(1) doi: 10.1186/1478-4505-9-32
|
| 4 |
Chen-Shiou Wu, Teng-Yu Lee, Ruey-Hwang Chou, Chia-Jui Yen, Wei-Chien Huang, Chung-Yi Wu, Yung-Luen Yu, Isabelle A. Chemin. Development of a Highly Sensitive Glycan Microarray for Quantifying AFP-L3 for Early Prediction of Hepatitis B Virus–Related Hepatocellular Carcinoma. PLoS ONE 2014; 9(6): e99959 doi: 10.1371/journal.pone.0099959
|
| 5 |
Ji De, Yi Shen, Jinyu Qin, Li Feng, Yiping Wang, Li Yang. A Systematic Review of Des-γ-Carboxy Prothrombin for the Diagnosis of Primary Hepatocellular Carcinoma. Medicine 2016; 95(17): e3448 doi: 10.1097/MD.0000000000003448
|
| 6 |
Matthew R. Woeste, Anne E. Geller, Robert C. G. Martin, Hiram C. Polk. Optimizing the Combination of Immunotherapy and Trans-Arterial Locoregional Therapy for Stages B and C Hepatocellular Cancer. Annals of Surgical Oncology 2021; 28(3): 1499 doi: 10.1245/s10434-020-09414-5
|
| 7 |
Mohamed IF Shariff, I Jane Cox, Asmaa I Gomaa, Shahid A Khan, Wladyslaw Gedroyc, Simon D Taylor-Robinson. Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis and therapeutics. Expert Review of Gastroenterology & Hepatology 2009; 3(4): 353 doi: 10.1586/egh.09.35
|
| 8 |
Magdy Hamed Attwa, Shahira Aly El-Etreby. Guide for diagnosis and treatment of hepatocellular carcinoma. World Journal of Hepatology 2015; 7(12): 1632-1651 doi: 10.4254/wjh.v7.i12.1632
|
| 9 |
Zu‐Yau Lin, Chun‐Chieh Wu, Yen‐Hwang Chuang, Wan‐Long Chuang. Clinical utility of a simple primary culture method in hepatocellular carcinoma patients. Journal of Gastroenterology and Hepatology 2015; 30(2): 352 doi: 10.1111/jgh.12693
|
| 10 |
Nabil Mohie Abdel-Hamid, Shimaa Ali Abass. Handbook of Cancer and Immunology. 2023; : 1 doi: 10.1007/978-3-030-80962-1_148-1
|
| 11 |
Peter R. Galle, Masatoshi Kudo, Josep M. Llovet, Richard S. Finn, Mark Karwal, Denis Pezet, Tae‐You Kim, Tsai‐Sheng Yang, Sara Lonardi, Jiri Tomasek, Jean‐Marc Phelip, Yann Touchefeu, Su‐Jin Koh, Guido Stirnimann, Kun Liang, Kenyon D. Ogburn, Chunxiao Wang, Paolo Abada, Ryan C. Widau, Andrew X. Zhu. Ramucirumab in patients with previously treated advanced hepatocellular carcinoma: Impact of liver disease aetiology. Liver International 2021; 41(11): 2759 doi: 10.1111/liv.14994
|
| 12 |
JIANPING WANG, DEJIE LIU, XIAOHONG LIANG, LIFEN GAO, XUETIAN YUE, YANG YANG, CHUNHONG MA, JUN LIU. Construction of a recombinant eukaryotic human ZHX1 gene expression plasmid and the role of ZHX1 in hepatocellular carcinoma. Molecular Medicine Reports 2013; 8(5): 1531 doi: 10.3892/mmr.2013.1700
|
| 13 |
Constantinos T. Sofocleous, Panagiotis Sideras, Elena N. Petre. “How We Do it”—A Practical Approach to Hepatic Metastases Ablation Techniques. Techniques in Vascular and Interventional Radiology 2013; 16(4): 219 doi: 10.1053/j.tvir.2013.08.005
|
| 14 |
Kevin Z Qu, Ke Zhang, Wanlong Ma, Hairong Li, Xiuqiang Wang, Xi Zhang, Francis Giles, Michelle Lai, Nezam H Afdhal, Maher Albitar. Ubiquitin‐proteasome profiling for enhanced detection of hepatocellular carcinoma in patients with chronic liver disease. Journal of Gastroenterology and Hepatology 2011; 26(4): 751 doi: 10.1111/j.1440-1746.2010.06491.x
|
| 15 |
Marika Santarsiere, Mariateresa Rumolo, Emilia Vergara, Arturo Brunetti, Pietro Gisonni. Microvascular Flow Imaging in a Case of Portal Vein Thrombosis. Journal for Vascular Ultrasound 2022; 46(1): 27 doi: 10.1177/15443167211033599
|
| 16 |
Yeong Hee Ahn, Park Min Shin, Eun Sun Ji, Hoguen Kim, Jong Shin Yoo. A lectin-coupled, multiple reaction monitoring based quantitative analysis of human plasma glycoproteins by mass spectrometry. Analytical and Bioanalytical Chemistry 2012; 402(6): 2101 doi: 10.1007/s00216-011-5646-3
|
| 17 |
Ewelina Jurewicz, Irena Kasacka, Edward Bańkowski, Anna Filipek. Identification and localization of S100A6 in human umbilical cord. Cell Biology International 2012; 36(1): 109 doi: 10.1042/CBI20110233
|
| 18 |
Russell N. Wesson, Andrew M. Cameron. Primary Liver Cancer. 2012; : 79 doi: 10.1007/978-1-61779-863-4_5
|
| 19 |
Saber Ismail, Wael Mayah, Hassan El Battia, Hanaa Gaballah, Asif Jiman-Fatani, Hala Hamouda, Mohamed A. Afifi, Nehal Elmashad, Sherif El Saadany. Plasma Nuclear Factor Kappa B and Serum Peroxiredoxin 3 in Early Diagnosis of Hepatocellular Carcinoma. Asian Pacific Journal of Cancer Prevention 2015; 16(4): 1657 doi: 10.7314/APJCP.2015.16.4.1657
|
| 20 |
Elaine Holmes, Ian D. Wilson, John C. Lindon. The Handbook of Metabolic Phenotyping. 2019; : 1 doi: 10.1016/B978-0-12-812293-8.00001-3
|
| 21 |
Reetta Holmila, Athena Sklias, David C. Muller, Davide Degli Esposti, Paule Guilloreau, James Mckay, Suleeporn Sangrajrang, Petcharin Srivatanakul, Pierre Hainaut, Philippe Merle, Zdenko Herceg, Andre Nogueira da Costa, John Luk. Targeted deep sequencing of plasma circulating cell-free DNA reveals Vimentin and Fibulin 1 as potential epigenetic biomarkers for hepatocellular carcinoma. PLOS ONE 2017; 12(3): e0174265 doi: 10.1371/journal.pone.0174265
|
| 22 |
Longbo Hu, Wenxia Yao, Fang Wang, Xia Rong, Tao Peng, Hong Wanjin. GP73 Is Upregulated by Hepatitis C Virus (HCV) Infection and Enhances HCV Secretion. PLoS ONE 2014; 9(3): e90553 doi: 10.1371/journal.pone.0090553
|
| 23 |
Manar Mahmoud El-Tonsy, Hesham Mohammed Hussein, Thanaa El-Sayed Helal, Rania Ayman Tawfik, Khalid Mohamed Koriem, Hend Mohamed Hussein. Schistosoma mansoni infection: Is it a risk factor for development of hepatocellular carcinoma?. Acta Tropica 2013; 128(3): 542 doi: 10.1016/j.actatropica.2013.07.024
|
| 24 |
Sivapatham Sundaresan, Palanirasu Rajapriya. Translational Research in Cancer. 2021; doi: 10.5772/intechopen.94769
|
| 25 |
Dina M. Rasheed Bahgat, Rasha Mohamad Hosny Shahin, Nada Nasr Makar, Ashraf Omar Abdel Aziz, Shereen Shoukry Hunter. Reversion‐Inducing‐Cysteine‐Rich Protein With Kazal Motifs (RECK) Gene Single Nucleotide Polymorphism With Hepatocellular Carcinoma: A Case–Control Study. Journal of Clinical Laboratory Analysis 2016; 30(1): 36 doi: 10.1002/jcla.21806
|
| 26 |
Sudhakar Rajoria, Sarita Rani, Dasharath Chaudhari, Sanyog Jain, Umesh Gupta. Glycine-Poly-L-Lactic Acid Copolymeric Nanoparticles for the Efficient Delivery of Bortezomib. Pharmaceutical Research 2019; 36(11) doi: 10.1007/s11095-019-2686-4
|
| 27 |
Huaqing Cui, Feng Wu, Yanling Sun, Guocai Fan, Qingming Wang. Up-regulation and subcellular localization of hnRNP A2/B1 in the development of hepatocellular carcinoma. BMC Cancer 2010; 10(1) doi: 10.1186/1471-2407-10-356
|
| 28 |
Catharine M Sturgeon, Michael J Duffy, Barry R Hofmann, Rolf Lamerz, Herbert A Fritsche, Katja Gaarenstroom, Johannes Bonfrer, Thorsten H Ecke, H Barton Grossman, Peter Hayes, Ralf-Thorsten Hoffmann, Seth P Lerner, Florian Löhe, Johanna Louhimo, Ihor Sawczuk, Kazuhisa Taketa, Eleftherios P Diamandis. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Liver, Bladder, Cervical, and Gastric Cancers. Clinical Chemistry 2010; 56(6): e1 doi: 10.1373/clinchem.2009.133124
|
| 29 |
Heba S. El Deen, Hemmat E. El Haddad. Significance of hepatocyte growth factor concentrations in serum of patients with liver cirrhosis and patients with hepatocellular carcinoma. The Egyptian Journal of Internal Medicine 2015; 27(3): 92 doi: 10.4103/1110-7782.165437
|
| 30 |
M.-O. Riener. Diagnose von Tumoren der Leber und Gallenwege. Der Pathologe 2011; 32(S2): 304 doi: 10.1007/s00292-011-1467-6
|
| 31 |
Andrew X Zhu, Joon Oh Park, Baek-Yeol Ryoo, Chia-Jui Yen, Ronnie Poon, Davide Pastorelli, Jean-Frederic Blanc, Hyun Cheol Chung, Ari D Baron, Tulio Eduardo Flesch Pfiffer, Takuji Okusaka, Katerina Kubackova, Jorg Trojan, Javier Sastre, Ian Chau, Shao-Chun Chang, Paolo B Abada, Ling Yang, Jonathan D Schwartz, Masatoshi Kudo. Ramucirumab versus placebo as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib (REACH): a randomised, double-blind, multicentre, phase 3 trial. The Lancet Oncology 2015; 16(7): 859 doi: 10.1016/S1470-2045(15)00050-9
|
| 32 |
Brian C. Grieb, Laura W. Goff, Lipika Goyal, Crystal S. Denlinger. Evolving Landscape of Systemic Therapy for Hepatocellular Carcinoma: Breakthroughs, Toxicities, and Future Frontiers. American Society of Clinical Oncology Educational Book 2019; (39): 248 doi: 10.1200/EDBK_237555
|
| 33 |
Jin Un Kim, Mohamed I F Shariff, Mary M E Crossey, Maria Gomez-Romero, Elaine Holmes, I Jane Cox, Haddy K S Fye, Ramou Njie, Simon D Taylor-Robinson. Hepatocellular carcinoma: Review of disease and tumor biomarkers. World Journal of Hepatology 2016; 8(10): 471-484 doi: 10.4254/wjh.v8.i10.471
|
| 34 |
María Muros-Ortega, Mª Sacramento Díaz-Carrasco, Antonio Capel, Miguel Ángel Calleja, Fernando Martínez. Effectiveness and safety of doxorubicin loaded beads in hepatocellular carcinoma. International Journal of Clinical Pharmacy 2013; 35(6): 1105 doi: 10.1007/s11096-013-9831-7
|
| 35 |
Yeong Hee Ahn, Eun Sun Ji, Park Min Shin, Kwang Hoe Kim, Yong-Sam Kim, Jeong Heon Ko, Jong Shin Yoo. A multiplex lectin-channel monitoring method for human serum glycoproteins by quantitative mass spectrometry. The Analyst 2012; 137(3): 691 doi: 10.1039/C1AN15775B
|
| 36 |
Kohei Ogawa, Toshimi Kaido, Hideaki Okajima, Yasuhiro Fujimoto, Atsushi Yoshizawa, Shintaro Yagi, Tomohide Hori, Taku Iida, Yasutsugu Takada, Shinji Uemoto. Impact of pretreatments on outcomes after living donor liver transplantation for hepatocellular carcinoma. Journal of Hepato-Biliary-Pancreatic Sciences 2019; 26(2): 73 doi: 10.1002/jhbp.602
|
| 37 |
Hao Yang, Guo-Dong Chen, Feng Fang, Zhen Liu, Stephanie Hiu Yan Lau, Jin-Fan Zhang, Wan Yee Lau, Lian-Yue Yang. Dickkopf-1: As a Diagnostic and Prognostic Serum Marker for Early Hepatocellular Carcinoma. The International Journal of Biological Markers 2013; 28(3): 286 doi: 10.5301/JBM.5000015
|
| 38 |
Mika Fujiwara, Shirley Kwok, Hirohisa Yano, Reetesh K. Pai. Arginase‐1 is a more sensitive marker of hepatic differentiation than HepPar‐1 and glypican‐3 in fine‐needle aspiration biopsies . Cancer Cytopathology 2012; 120(4): 230 doi: 10.1002/cncy.21190
|
| 39 |
János Fehér, Gabriella Lengyel. Hepatocellular carcinoma: occurrence, risk factors, biomarkers. Orvosi Hetilap 2010; 151(23): 933 doi: 10.1556/oh.2010.28900
|
| 40 |
Chia-Jui Yen, Masatoshi Kudo, Ho-Yeong Lim, Chih-Hung Hsu, Arndt Vogel, Giovanni Brandi, Rebecca Cheng, Ioana Simona Nitu, Paolo Abada, Yanzhi Hsu, Andrew X. Zhu, Yoon-Koo Kang. Efficacy and Safety of Ramucirumab in Asian and Non-Asian Patients with Advanced Hepatocellular Carcinoma and Elevated Alpha-Fetoprotein: Pooled Individual Data Analysis of Two Randomized Studies. Liver Cancer 2020; 9(4): 440 doi: 10.1159/000506946
|
| 41 |
Hosni M. Salama, Hanan Abdel-Haleem, Fatma M. Taha, Rasha A. Abdel-Azeez, Raghda N. Marzaban, Saeed M. El-Nahaas, Tarneem Darwish. Plasma proteosome level as a potential marker for hepatocellular carcinoma. Arab Journal of Gastroenterology 2013; 14(3): 87 doi: 10.1016/j.ajg.2013.09.002
|
| 42 |
Young Mi Hong, K. T. Yoon, Mong Cho. Systemic immune-inflammation index predicts prognosis of sequential therapy with sorafenib and regorafenib in hepatocellular carcinoma. BMC Cancer 2021; 21(1) doi: 10.1186/s12885-021-08124-9
|
| 43 |
Zhongguo Zhou, Minshan Chen. Radiofrequency Ablation for Small Hepatocellular Carcinoma. 2016; : 39 doi: 10.1007/978-94-017-7258-7_5
|
| 44 |
Toshimi Kaido, Kohei Ogawa, Akira Mori, Yasuhiro Fujimoto, Takashi Ito, Koji Tomiyama, Yasutsugu Takada, Shinji Uemoto. Usefulness of the Kyoto criteria as expanded selection criteria for liver transplantation for hepatocellular carcinoma. Surgery 2013; 154(5): 1053 doi: 10.1016/j.surg.2013.04.056
|
| 45 |
Yuxin Liang, Zilong Zhang, Deyuan Zhong, Chunyou Lai, Zonglin Dai, Haibo Zou, Tianhang Feng, Jin Shang, Ying Shi, Xiaolun Huang. The prognostic significance of inflammation-immunity-nutrition score on postoperative survival and recurrence in hepatocellular carcinoma patients. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.913731
|
| 46 |
Sene Waly Raphael, Zhang Yangde, Chen YuXiang. Hepatocellular Carcinoma: Focus on Different Aspects of Management. ISRN Oncology 2012; 2012: 1 doi: 10.5402/2012/421673
|
| 47 |
Yeong Hee Ahn, Jin Young Kim, Jong Shin Yoo. Quantitative mass spectrometric analysis of glycoproteins combined with enrichment methods. Mass Spectrometry Reviews 2015; 34(2): 148 doi: 10.1002/mas.21428
|
| 48 |
K. Hamdy, R. Al Swaff, H. A. Hussein, M. Gamal. Assessment of serum adiponectin in Egyptian patients with HCV-related cirrhosis and hepatocellular carcinoma. Journal of Endocrinological Investigation 2015; 38(11): 1225 doi: 10.1007/s40618-015-0379-3
|
| 49 |
Ming‐Tzung Lin, Chao‐Long Chen, Chih‐Chi Wang, Yu‐Fan Cheng, Hock‐Liew Eng, Jing‐Houng Wang, King‐Wah Chiu, Chuan‐Mo Lee, Tsung‐Hui Hu. Diagnostic sensitivity of hepatocellular carcinoma imaging and its application to non‐cirrhotic patients. Journal of Gastroenterology and Hepatology 2011; 26(4): 745 doi: 10.1111/j.1440-1746.2010.06501.x
|
| 50 |
Fayza A. Rahamtalla, Mohammed S. M. Abdalla, Salma B. M. Mudawi, Mohammed A. H. Kheir Elsid, Iman M. Shammat. Estimation of telomerase, AFP, and AFP-L3 levels in Sudanese patients with hepatocellular carcinoma and chronic liver diseases. Comparative Clinical Pathology 2018; 27(5): 1133 doi: 10.1007/s00580-018-2709-2
|
| 51 |
Salma Binzaqr, Frederic Debordeaux, Jean-Frédéric Blanc, Panteleimon Papadopoulos, Elif Hindie, Bruno Lapouyade, Jean-Baptiste Pinaquy. Efficacy of Selective Internal Radiation Therapy for Hepatocellular Carcinoma Post-Incomplete Response to Chemoembolization. Pharmaceuticals 2023; 16(12): 1676 doi: 10.3390/ph16121676
|
| 52 |
Feng Hua Wang, Yuk Ching Yip, Meng Zhang, Heong Ting Vong, Kin Iong Chan, Kit Cheng Wai, Jian Ming Wen. Diagnostic utility of glypican-3 for hepatocellular carcinoma on liver needle biopsy. Journal of Clinical Pathology 2010; 63(7): 599 doi: 10.1136/jcp.2010.075374
|
| 53 |
Ping Wu, Jean Jacques Dugoua, Oghenowede Eyawo, Edward J Mills. Traditional Chinese medicines in the treatment of hepatocellular cancers: a systematic review and meta-analysis. Journal of Experimental & Clinical Cancer Research 2009; 28(1) doi: 10.1186/1756-9966-28-112
|
| 54 |
Nikolaus Kohles, Stefan Holdenrieder. Biomarkers in Cancer. 2014; : 1 doi: 10.1007/978-94-007-7744-6_38-1
|
| 55 |
Jorge A. Marrero, Masatoshi Kudo, Jean-Pierre Bronowicki. The Challenge of Prognosis and Staging for Hepatocellular Carcinoma. The Oncologist 2010; 15(S4): 23 doi: 10.1634/theoncologist.2010-S4-23
|
| 56 |
Rafael Miret, Amir Riaz, Sikandar Khan, Asad Ur Rahman. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 3. 2022; : 275 doi: 10.1016/B978-0-323-99283-1.00010-0
|
| 57 |
Se Hun Kang, Do Young Kim, Soung Min Jeon, Sang Hoon Ahn, Jun Yong Park, Seung Up Kim, Ja Kyung Kim, Kwan Sik Lee, Chae Yoon Chon, Kwang-Hyub Han. Clinical characteristics and prognosis of hepatocellular carcinoma with different sets of serum AFP and PIVKA-II levels. European Journal of Gastroenterology & Hepatology 2012; 24(7): 849 doi: 10.1097/MEG.0b013e3283535c34
|
| 58 |
Gehan H. Ibrahim, Moushira A. Mahmoud, Nagwa M. Aly. Evaluation of circulating Transforming growth factor-beta1, Glypican-3 and Golgi protein-73 mRNAs expression as predictive markers for hepatocellular carcinoma in Egyptian patients. Molecular Biology Reports 2013; 40(12): 7069 doi: 10.1007/s11033-013-2829-3
|
| 59 |
Yeonjung Ha, Ju Hyun Shim, Seon‐Ok Kim, Kang Mo Kim, Young‐Suk Lim, Han Chu Lee. Clinical appraisal of the recently proposed Barcelona Clinic Liver Cancer stage B subclassification by survival analysis. Journal of Gastroenterology and Hepatology 2014; 29(4): 787 doi: 10.1111/jgh.12452
|
| 60 |
Marthandam Asokan Shibu, Yi‐Ju Chen, Hong‐Siang Yang, Yen‐Hua He, Yun‐Hsin Lo, Wan‐Teng Lin. Principle active metabolites of Pinus morrisonicolaHayata synergistically inhibit cell proliferation and autophagy to elevate apoptosis in hepatocellular carcinoma cells. Environmental Toxicology 2023; 38(12): 3018 doi: 10.1002/tox.23935
|
| 61 |
Giuseppe Derosa, Pamela Maffioli. Biomarkers in Liver Disease. Biomarkers in Disease: Methods, Discoveries and Applications 2016; : 1 doi: 10.1007/978-94-007-7742-2_13-1
|
| 62 |
Minoru Matsubara, Hidenori Shiraha, Jyunro Kataoka, Masaya Iwamuro, Shigeru Horiguchi, Shin‐ichi Nishina, Nobuyuki Takaoka, Masayuki Uemura, Akinobu Takaki, Shinichiro Nakamura, Yoshiyuki Kobayashi, Kazuhiro Nouso, Kazuhide Yamamoto. Des‐γ‐carboxyl prothrombin is associated with tumor angiogenesis in hepatocellular carcinoma. Journal of Gastroenterology and Hepatology 2012; 27(10): 1602 doi: 10.1111/j.1440-1746.2012.07173.x
|
| 63 |
Anan H. Said, Kirti Shetty, Ying Li, Boris Blechacz, Ernest Hawk, Lopa Mishra. Handbook of Gastrointestinal Cancer. 2012; : 161 doi: 10.1002/9781118423318.ch7
|
| 64 |
Mark A. Feitelson, Alla Arzumanyan, Helena M. G. P. V. Reis, Marcia M. Clayton, Bill S. Sun, Zhaorui Lian. Molecular Pathology of Liver Diseases. Molecular Pathology Library 2011; 5: 553 doi: 10.1007/978-1-4419-7107-4_37
|
| 65 |
Takeshi Ishihara, Isao Fukuda, Atsushi Morita, Yoshihiko Takinami, Hiroyuki Okamoto, Shin-Ichiro Nishimura, Yoshito Numata. Development of quantitative plasma N-glycoproteomics using label-free 2-D LC-MALDI MS and its applicability for biomarker discovery in hepatocellular carcinoma. Journal of Proteomics 2011; 74(10): 2159 doi: 10.1016/j.jprot.2011.06.010
|
| 66 |
Li Huo, Zhanhong Wu, Hongming Zhuang, Zhe Fu, Yonghong Dang. Dual Time Point C-11 Acetate PET Imaging Can Potentially Distinguish Focal Nodular Hyperplasia From Primary Hepatocellular Carcinoma. Clinical Nuclear Medicine 2009; 34(12): 874 doi: 10.1097/RLU.0b013e3181bed06e
|
| 67 |
Tomokazu Kawaoka, Hiroshi Aikata, Hiromi Kan, Hatsue Fujino, Takayuki Fukuhara, Tomoki Kobayashi, Noriaki Naeshiro, Daisuke Miyaki, Akira Hiramatsu, Michio Imamura, Yoshiiku Kawakami, Hideyuki Hyogo, Kazuaki Chayama. Clinical outcome and prognostic factors of patients with hepatocellular carcinoma and extrahepatic metastasis treated with sorafenib. Hepatology Research 2014; 44(13): 1320 doi: 10.1111/hepr.12307
|
| 68 |
Ming Shi, Min-Shan Chen, Karthik Sekar, Chee-Kiat Tan, London Lucien Ooi, Kam M. Hui. A blood-based three-gene signature for the non-invasive detection of early human hepatocellular carcinoma. European Journal of Cancer 2014; 50(5): 928 doi: 10.1016/j.ejca.2013.11.026
|
| 69 |
Ian Chau, Joon Oh Park, Baek-Yeol Ryoo, Chia-Jui Yen, Ronnie Poon, Davide Pastorelli, Jean-Frédéric Blanc, Masatoshi Kudo, Tulio Pfiffer, Etsuro Hatano, Hyun Cheol Chung, Katerina Kopeckova, Jean-Marc Phelip, Giovanni Brandi, Shinichi Ohkawa, Chung-Pin Li, Takuji Okusaka, Yanzhi Hsu, Paolo B. Abada, Andrew X. Zhu. Alpha-fetoprotein kinetics in patients with hepatocellular carcinoma receiving ramucirumab or placebo: an analysis of the phase 3 REACH study. British Journal of Cancer 2018; 119(1): 19 doi: 10.1038/s41416-018-0103-0
|
| 70 |
Siwei Wei, Yuliana Suryani, G. A. Nagana Gowda, Nicholas Skill, Mary Maluccio, Daniel Raftery. Differentiating Hepatocellular Carcinoma from Hepatitis C Using Metabolite Profiling. Metabolites 2012; 2(4): 701 doi: 10.3390/metabo2040701
|
| 71 |
Fatma Shehata, Nihad Abdel Monem, Mohamed Sakr, Samar Kasem, Mahmoud Balbaa. Epidermal growth factor, its receptor and transforming growth factor-β1 in the diagnosis of HCV-induced hepatocellular carcinoma. Medical Oncology 2013; 30(3) doi: 10.1007/s12032-013-0673-x
|
| 72 |
Hammad Zafar, Mamoon Ur Rashid, Deepika Sarvepalli, Muzammil Muhammad Khan, Bayarmaa Mandzhieva, Akriti Gupta Jain, Rima Shobar, Anum Jalil, Sarfraz Ahmad. Phytochemicals Targeting Tumor Microenvironment in Gastrointestinal Cancers. 2020; : 287 doi: 10.1007/978-3-030-48405-7_13
|
| 73 |
David J. S. Becker-Weidman, Bobby Kalb, Puneet Sharma, Hiroumi D. Kitajima, Christina R. Lurie, Zhengjia Chen, James R. Spivey, Stuart J. Knechtle, Steven I. Hanish, N. Volkan Adsay, Alton B. Farris, Diego R. Martin. Hepatocellular Carcinoma Lesion Characterization: Single-Institution Clinical Performance Review of Multiphase Gadolinium-enhanced MR Imaging—Comparison to Prior Same-Center Results after MR Systems Improvements. Radiology 2011; 261(3): 824 doi: 10.1148/radiol.11110157
|
| 74 |
Yeong Hee Ahn, Eun Sun Ji, Na Ree Oh, Yong-Sam Kim, Jeong Heon Ko, Jong Shin Yoo. Differential proteomic approach for identification and verification of aberrantly glycosylated proteins in adenocarcinoma lung cancer (ADLC) plasmas by lectin-capturing and targeted mass spectrometry. Journal of Proteomics 2014; 106: 221 doi: 10.1016/j.jprot.2014.04.031
|
| 75 |
Yeong Hee Ahn, Park Min Shin, Na Ree Oh, Gun Wook Park, Hoguen Kim, Jong Shin Yoo. A lectin-coupled, targeted proteomic mass spectrometry (MRM MS) platform for identification of multiple liver cancer biomarkers in human plasma. Journal of Proteomics 2012; 75(17): 5507 doi: 10.1016/j.jprot.2012.06.027
|
| 76 |
Keun Na, Seul‐Ki Jeong, Min Jung Lee, Sang Yun Cho, Sun A Kim, Min‐Ji Lee, Si Young Song, Hoguen Kim, Kyung Sik Kim, Hyun Woong Lee, Young‐Ki Paik. Human liver carboxylesterase 1 outperforms alpha‐fetoprotein as biomarker to discriminate hepatocellular carcinoma from other liver diseases in Korean patients. International Journal of Cancer 2013; 133(2): 408 doi: 10.1002/ijc.28020
|
| 77 |
Suzanne Chabert, Samuele Iesari, Geraldine Dahlqvist, Mina Komuta, Pamela Baldin, Evaldo Favi, Laurent Coubeau. Association of Serum Levels and Immunohistochemical Labelling of Des-Gamma-Carboxy-Prothrombin in Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma. Diagnostics 2024; 14(9): 894 doi: 10.3390/diagnostics14090894
|
| 78 |
Keun Na, Minjoo Kim, Chae-Yeon Kim, Jong-Sun Lim, Jin-Young Cho, Heon Shin, Hyo Jin Lee, Byeong Jun Kang, Dai Hoon Han, Hoguen Kim, Ja-Hyun Baik, Magdalena Swiatek-de Lange, Johann Karl, Young-Ki Paik. Potential Regulatory Role of Human-Carboxylesterase-1 Glycosylation in Liver Cancer Cell Growth. Journal of Proteome Research 2020; 19(12): 4867 doi: 10.1021/acs.jproteome.0c00787
|
| 79 |
Kun-Ming Rau, Chien-Ting Liu, Yu-Chiao Hsiao, Kai-Yin Hsiao, Tzu-Min Wang, Wei-Shan Hung, Yu-Li Su, Wei-Ching Liu, Cheng-Hsu Wang, Hsueh-Ling Hsu, Po-Heng Chuang, Ju-Chien Cheng, Ching-Ping Tseng. Sequential Circulating Tumor Cell Counts in Patients with Locally Advanced or Metastatic Hepatocellular Carcinoma: Monitoring the Treatment Response. Journal of Clinical Medicine 2020; 9(1): 188 doi: 10.3390/jcm9010188
|
| 80 |
Caroline D. M. Witjes, Susanna M. van Aalten, Ewout W. Steyerberg, Gerard J. J. M. Borsboom, Robert A. de Man, Cornelis Verhoef, Jan N. M. IJzermans. Recently introduced biomarkers for screening of hepatocellular carcinoma: a systematic review and meta-analysis. Hepatology International 2013; 7(1): 59 doi: 10.1007/s12072-012-9374-3
|
| 81 |
C.-C. Liu, H. Yang, R. Zhang, J.-J. Zhao, D.-J. Hao. Tumour-associated antigens and their anti-cancer applications. European Journal of Cancer Care 2017; 26(5): e12446 doi: 10.1111/ecc.12446
|
| 82 |
Andre Nogueira da Costa, Amelie Plymoth, Daniela Santos-Silva, Sandra Ortiz-Cuaran, Suzy Camey, Paule Guilloreau, Suleeporn Sangrajrang, Thiravud Khuhaprema, Maimuna Mendy, Olufunmilayo A. Lesi, Hee-Kyung Chang, Jin-Kyoung Oh, Duk-Hee Lee, Hai-Rim Shin, Gregory D. Kirk, Philippe Merle, Laura Beretta, Pierre Hainaut. Osteopontin and latent-TGF β binding-protein 2 as potential diagnostic markers for HBV-related hepatocellular carcinoma. International Journal of Cancer 2015; 136(1): 172 doi: 10.1002/ijc.28953
|
| 83 |
JING ZHU, FENG JIANG, HONG-BING NI, MING-BING XIAO, BU-YOU CHEN, WEN-KAI NI, CUI-HUA LU, RUN-ZHOU NI. Combined analysis of serum γ-glutamyl transferase isoenzyme II, α-L-fucosidase and α-fetoprotein detected using a commercial kit in the diagnosis of hepatocellular carcinoma. Experimental and Therapeutic Medicine 2013; 5(1): 89 doi: 10.3892/etm.2012.783
|
| 84 |
Qian Shang, Jun-Feng Xiang, Ya-Lin Tang. NMR-based metabonomics: a useful platform of oncology research. Bioanalytical Reviews 2010; 1(2-4): 117 doi: 10.1007/s12566-010-0009-7
|
| 85 |
Elaine Holmes, Anisha Wijeyesekera, Simon D. Taylor-Robinson, Jeremy K. Nicholson. The promise of metabolic phenotyping in gastroenterology and hepatology. Nature Reviews Gastroenterology & Hepatology 2015; 12(8): 458 doi: 10.1038/nrgastro.2015.114
|
| 86 |
Nikolaus Kohles, Stefan Holdenrieder. Biomarkers in Cancer. Biomarkers in Disease: Methods, Discoveries and Applications 2015; : 303 doi: 10.1007/978-94-007-7681-4_38
|
| 87 |
Shivani Krishnamurthy, David Gilot, Seong Beom Ahn, Vincent Lam, Joo-Shik Shin, Gilles Jackie Guillemin, Benjamin Heng. Involvement of Kynurenine Pathway in Hepatocellular Carcinoma. Cancers 2021; 13(20): 5180 doi: 10.3390/cancers13205180
|
| 88 |
Ana L. M. Pavan, Marwa Benabdallah, Marie-Ange Lebre, Diana Rodrigues de Pina, Faouzi Jaziri, Antoine Vacavant, Achraf Mtibaa, Hawa Mohamed Ali, Manuel Grand-Brochier, Hugo Rositi, Benoît Magnin, Armand Abergel, Pascal Chabrot. A parallel framework for HCC detection in DCE-MRI sequences with wavelet-based description and SVM classification. Proceedings of the 33rd Annual ACM Symposium on Applied Computing 2018; : 14 doi: 10.1145/3167132.3167167
|
| 89 |
Toshimi Kaido, Satoshi Morita, Sachiko Tanaka, Kohei Ogawa, Akira Mori, Etsuro Hatano, Shinji Uemoto. Long-Term Outcomes of Hepatic Resection versus Living Donor Liver Transplantation for Hepatocellular Carcinoma: A Propensity Score-Matching Study. Disease Markers 2015; 2015: 1 doi: 10.1155/2015/425926
|
| 90 |
Anita Gupta. Emerging applications of lectins in cancer detection and biomedicine. Materials Today: Proceedings 2020; 31: 651 doi: 10.1016/j.matpr.2020.05.810
|
| 91 |
Carmine Finelli, Giovanni Tarantino. Should visceral fat, strictly linked to hepatic steatosis, be depleted to improve survival?. Hepatology International 2013; 7(2): 413 doi: 10.1007/s12072-012-9406-z
|
| 92 |
Fatih Özdemir, Adil Baskiran. The Importance of AFP in Liver Transplantation for HCC. Journal of Gastrointestinal Cancer 2020; 51(4): 1127 doi: 10.1007/s12029-020-00486-w
|
| 93 |
Kwang Hoe Kim, Jin Young Kim, Jong Shin Yoo. Mass spectrometry analysis of glycoprotein biomarkers in human blood of hepatocellular carcinoma. Expert Review of Proteomics 2019; 16(7): 553 doi: 10.1080/14789450.2019.1626235
|
| 94 |
Ana F. Brito, Mónica Mendes, Ana M. Abrantes, José G. Tralhão, Maria F. Botelho. Positron Emission Tomography Diagnostic Imaging in Multidrug-Resistant Hepatocellular Carcinoma: Focus on 2-Deoxy-2-(18F)Fluoro-d-Glucose. Molecular Diagnosis & Therapy 2014; 18(5): 495 doi: 10.1007/s40291-014-0106-3
|
| 95 |
Amandeep Kaur, Ajay Pal Singh Chauhan, Ashwani Kumar Aggarwal. An automated slice sorting technique for multi-slice computed tomography liver cancer images using convolutional network. Expert Systems with Applications 2021; 186: 115686 doi: 10.1016/j.eswa.2021.115686
|
| 96 |
Madhvi Patel, Mohamed I.F. Shariff, Nimzing G. Ladep, Andrew V. Thillainayagam, Howard C. Thomas, Shahid A. Khan, Simon D. Taylor‐Robinson. Hepatocellular carcinoma: diagnostics and screening. Journal of Evaluation in Clinical Practice 2012; 18(2): 335 doi: 10.1111/j.1365-2753.2010.01599.x
|
| 97 |
Yujun Kim, Hui Li, Joohee Choi, Jihyeon Boo, Hyemi Jo, Ji Young Hyun, Injae Shin. Glycosidase-targeting small molecules for biological and therapeutic applications. Chemical Society Reviews 2023; 52(20): 7036 doi: 10.1039/D3CS00032J
|
| 98 |
Bo Li, Boan Li, Tongsheng Guo, Zhiqiang Sun, Xiaohan Li, Xiaoxi Li, Han Wang, Weijiao Chen, Peng Chen, Yuanli Mao. The Clinical Values of Serum Markers in the Early Prediction of Hepatocellular Carcinoma. BioMed Research International 2017; 2017: 1 doi: 10.1155/2017/5358615
|
| 99 |
Ilse du Preez, Nomathamsanqa P. Sithebe. The use of metabolomics as a tool to investigate hepatitis C. Metabolomics 2013; 9(2): 497 doi: 10.1007/s11306-012-0467-8
|
| 100 |
Kyeong-Ah Lee, Ji-Young Ahn, Sang-Hee Lee, Simranjeet Singh Sekhon, Dae-Ghon Kim, Jiho Min, Yang-Hoon Kim. Aptamer-based Sandwich Assay and its Clinical Outlooks for Detecting Lipocalin-2 in Hepatocellular Carcinoma (HCC). Scientific Reports 2015; 5(1) doi: 10.1038/srep10897
|
| 101 |
Samantha Marglous, Claire E. Brown, Vered Padler-Karavani, Richard D. Cummings, Jeffrey C. Gildersleeve. Serum antibody screening using glycan arrays. Chemical Society Reviews 2024; 53(5): 2603 doi: 10.1039/D3CS00693J
|
| 102 |
Amy C. McClune, Myron J. Tong. Chronic Hepatitis B and Hepatocellular Carcinoma. Clinics in Liver Disease 2010; 14(3): 461 doi: 10.1016/j.cld.2010.05.009
|
| 103 |
Nannan Fan, Ping Li, Yongqing Zhou, Chuanchen Wu, Xin Wang, Zhenzhen Liu, Bo Tang. Demystifying Lysosomal α-l-Fucosidase in Liver Cancer-Bearing Mice by Specific Two-Photon Fluorescence Imaging. ACS Sensors 2022; 7(1): 71 doi: 10.1021/acssensors.1c01630
|
| 104 |
Anna Fabijańska, Antoine Vacavant, Marie-Ange Lebre, Ana L. M. Pavan, Diana R. de Pina, Armand Abergel, Pascal Chabrot, Benoît Magnin. Computer Vision and Graphics. Lecture Notes in Computer Science 2018; 11114: 319 doi: 10.1007/978-3-030-00692-1_28
|
| 105 |
Walifa Waqar, Sidra Asghar, Sobia Manzoor, Gianfranco D. Alpini. Platelets’ RNA as biomarker trove for differentiation of early-stage hepatocellular carcinoma from underlying cirrhotic nodules. PLOS ONE 2021; 16(9): e0256739 doi: 10.1371/journal.pone.0256739
|
| 106 |
Xin-Fei Xu, Lei Liang, Hao Xing, Feng Shen, Dong-Sheng Huang, Wan Y Lau, Tian Yang. Clinical Utility of Serum Biomarkers for Hepatocellular Carcinoma. Biomarkers in Medicine 2021; 15(3): 151 doi: 10.2217/bmm-2020-0474
|
| 107 |
Aymeric Becq, Christian Mateescu, David Khayat, Mohamed Bouattour. Atypical Presentation of Hepatocellular Carcinoma Mimicking a Gastric Hepatoid Adenocarcinoma. Medicine 2015; 94(27): e1101 doi: 10.1097/MD.0000000000001101
|
| 108 |
Sayo Kobayashi, Kazuhiro Nouso, Hideaki Kinugasa, Yasuto Takeuchi, Takeshi Tomoda, Koji Miyahara, Hiroaki Hagihara, Kenji Kuwaki, Hideki Onishi, Shinichiro Nakamura, Fusao Ikeda, Yasuhiro Miyake, Hidenori Shiraha, Akinobu Takaki, Kazuhide Yamamoto. Clinical utility of serum fucosylated hemopexin in Japanese patients with hepatocellular carcinoma. Hepatology Research 2012; 42(12): 1187 doi: 10.1111/j.1872-034X.2012.01044.x
|
| 109 |
Hoda Aly Abd El Moety, Dalia Aly Maharem, Salwa Hamdy Gomaa. Serotonin: is it a marker for the diagnosis of hepatocellular carcinoma in cirrhotic patients?. Alexandria Journal of Medicine 2013; 49(4): 369 doi: 10.1016/j.ajme.2013.03.010
|
| 110 |
Eun Sun Ji, Heeyoun Hwang, Gun Wook Park, Ju Yeon Lee, Hyun Kyoung Lee, Na Young Choi, Hoi Keun Jeong, Kwang Hoe Kim, Jin Young Kim, Seungho Lee, Yeong Hee Ahn, Jong Shin Yoo. Analysis of fucosylation in liver-secreted N-glycoproteins from human hepatocellular carcinoma plasma using liquid chromatography with tandem mass spectrometry. Analytical and Bioanalytical Chemistry 2016; 408(27): 7761 doi: 10.1007/s00216-016-9878-0
|
| 111 |
Felix H. Shek, Tracy C. W. Lai, Sarwat Fatima, Nikki P. Lee. New Advances on Disease Biomarkers and Molecular Targets in Biomedicine. 2013; : 57 doi: 10.1007/978-1-62703-456-2_4
|
| 112 |
Hua Yang, Fuxia Xiong, Ruizhao Qi, Zhenwen Liu, Ming Lin, Jingan Rui, Jing Su, Rouli Zhou. LAPTM4B‐35 is a novel prognostic factor of hepatocellular carcinoma. Journal of Surgical Oncology 2010; 101(5): 363 doi: 10.1002/jso.21489
|
| 113 |
Sen-Yung Hsieh, Jung-Ru He, Ming-Chin Yu, Wei-Chen Lee, Tse-Chin Chen, Shao-Jung Lo, Rabindranath Bera, Chang-Mung Sung, Cheng-Tang Chiu. Secreted ERBB3 Isoforms Are Serum Markers for Early Hepatoma in Patients with Chronic Hepatitis and Cirrhosis. Journal of Proteome Research 2011; 10(10): 4715 doi: 10.1021/pr200519q
|
| 114 |
Li‑Min Luo, Hu Xia, Rong Shi, Jun Zeng, Xin‑Rui Liu, Min Wei. The association between aquaporin‑1 expression, microvessel density and the clinicopathological features of hepatocellular carcinoma. Oncology Letters 2017; doi: 10.3892/ol.2017.7106
|
| 115 |
Miriama Smajerova, Hana Petrasova, Jirina Little, Petra Ovesna, Tomas Andrasina, Vlastimil Valek, Eva Nemcova, Barbora Miklosova. Contrast-enhanced ultrasonography in the evaluation of incidental focal liver lesions: A cost-effectiveness analysis. World Journal of Gastroenterology 2016; 22(38): 8605-8614 doi: 10.3748/wjg.v22.i38.8605
|
| 116 |
Gaeun Lee, Jieun Kim, June-Goo Lee, Geunhwi Ahn, Seong Ho Park, So Yeon Kim, Kyung Won Kim, Seung Soo Lee, Namkug Kim, Hiroshi Fujita, Feng Lin, Jong Hyo Kim. Automatic hepatocellular carcinoma lesion detection with dynamic enhancement characteristic from multi-phase CT images. International Forum on Medical Imaging in Asia 2019 2019; : 13 doi: 10.1117/12.2521021
|
| 117 |
Giovanni Morana, Luigi Grazioli, Miles A. Kirchin, Maria Pia Bondioni, Niccolò Faccioli, Alessandro Guarise, Günther Schneider. Solid Hypervascular Liver Lesions. Investigative Radiology 2011; 46(4): 225 doi: 10.1097/RLI.0b013e3181feee3a
|